Antimicrobial and antineoplastic activities of agelasine analogs modified in the purine 2-position

Archiv der Pharmazie

Volumn 344, Issue 1, 2011, Pages 50-55

  Roggen, Heidi ^a   Charnock, Colin ^b   Burman, Robert ^c   Felth, Jenny ^c   Larsson, Rolf ^d   Bohlin, Lars ^c   Gundersen, Lise Lotte ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO METROPOLITAN UNIVERSITY   (Norway)

^c UPPSALA UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Agelasine; Antibacterial activity; Anticancer acivitity; Antifungal activity; Antiprotozoal activity

Indexed keywords

2 CHLORO 6 METHOXYAMINO 9 METHYL 7 (3,7,11,15 TETRAMETHYL 2,6,10,14 HEXADECATETRAENYL) 7H PURINIUM; 2 CHLORO N METHOXY 9 METHYL N (3,7,11,15 TETRAMETHYL 2,6,10,14 HEXADECATETRAENYL) 9H PURIN 6 AMIN; 2 DIMETHYLAMINO 6 METHOXYAMINO 9 METHYL 7 (3,7,11,15 TETRAMETHYL 2,6,10,14 HEXADECATETRAENYL) 7H PURINIUM BROMIDE; 2 DIMETHYLAMINO N METHOXY 9 METHYL N 3,7,11,15 TETRAMETHYL 2,6,10,14 HEXADECATETRAENYL) 9H PURIN 6 AMIN; 2 ETHOXY 6 METHOXYAMINO 9 METHYL 7 (3,7,11,15 TETRAMETHYL 2,6,10,14 HEXADECATETRAENYL) 7H PURINIUM BROMIDE; 2 ETHOXY N METHOXY 9 METHYL N (3,7,11,15 TETRAMETHYL 2,6,10,14 HEXADECATETRAENYL) 9H PURIN 6 AMIN; 2 HYDROXY 6 METHOXYAMINO 9 METHYL 7 (3,7,11,15 TETRAMETHYL 2,6,10,14 HEXADECATETRAENYL) 7H PURINIUM; 2,9 DIMETHYL 6 METHOXYAMINO 7 (3,7,11,15 TETRAMETHYL 2,6,10,14 HEXADECATETRAENYL) 7H PURINIUM; 2,9 DIMETHYL N METHOXY N (3,7,11,15 TETRAMETHYL 2,6,10,14 HEXADECATETRAENYL) 9H PURIN 6 AMIN; 6 METHOXYAMINO 9 METHYL 2 METHYLAMINO 7 (3,7,11,15 TETRAMETHYL 2,6,10,14 HEXADECATETRAENYL) 7H PURINIUM BROMIDE; 7,9 DIALKYLPURINIUM; AGELASIMINE A; AGELASINE; N METHOXY 9 METHYL 2 METHYLAMINO N (3,7,11,15 TETRAMETHYL 2,6,10,14 HEXADECATETRAENYL) 9H PURIN 6 AMIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BENZYLATION; CANCER CELL CULTURE; CANDIDA ALBICANS; CANDIDA KRUSEI; DRUG SCREENING; DRUG SYNTHESIS; ESCHERICHIA COLI; HUMAN; HUMAN CELL; LEISHMANIA INFANTUM; MYCOBACTERIUM TUBERCULOSIS; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SPONGE (PORIFERA); STAPHYLOCOCCUS AUREUS; TRYPANOSOMA BRUCEI; TRYPANOSOMA CRUZI;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC AGENTS; ANTIPARASITIC AGENTS; CELL LINE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; HUMANS; NEOPLASMS; PURINES; STRUCTURE-ACTIVITY RELATIONSHIP; VERO CELLS;

EID: 78651307725     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201000148     Document Type: Article

References (25)

1. H. Nakamura, H. Wu, Y. Ohizumi, Y. Hirata, Tetrahedron Lett. 1984, 25, 2989-2992.
2. H. Wu, H. Nakamura, J. Kobayashi, Y. Ohizumi, Tetrahedron Lett. 1984, 25, 3719-3722.
3. R. J. Capon, D. J. Faulkner, J. Am. Chem. Soc. 1984, 106, 1819-1822.
4. H. Wu, H. Nakamura, J. Kobayashi, M. Kobayashi, Y. Ohizumi, Y. Hirata, Bull. Chem. Soc. Jpn. 1986, 59, 2495-2504.
5. T. Hattori, K. Adachi, Y. Shizuri, J. Nat. Prod. 1997, 60, 411-413.
6. X. Fu, F. J. Schmitz, R. S. Tanner, M. Kelly-Borges, J. Nat. Prod. 1998, 61, 548-550.
7. T. Iwagawa, M. Kaneko, H. Okamura, M. Nakatani, R. W. M. van Soest, J. Nat. Prod. 1998, 61, 1310-1312.
8. J. Appenzeller, G. Michi, M. Y. Martin, J. F. Gallard, J. M. Menou, N. Boury-Esnault, J. Hooper, S. Petek, S. Chevalley, A. Valentin, A. Zaparucha, A. Al-Mourabit, C. Debitus, J. Nat. Prod. 2008, 71, 1451-1454.
9. T. Hertiani, R. Edrada-Ebel, S. Ortlepp, R. W. M. van Soest, N. J. de Voogd, V. Wray, U. Hentschel, S. Kozytska, W. E. G. Müller, P. Proksch, Bioorg. Med. Chem. 2010, 18, 1297-1311.
10. B. T. Utenova, L.-L. Gundersen, Tetrahedron Lett. 2004, 45, 4233-4235.
11. A. Vik, E. Hedner, C. Charnock, Ã. Samuelsen, R. Larsson, L.-L. Gundersen, L. Bohlin, J. Nat. Prod. 2006, 69, 381-386.
12. A. K. Bakkestuen, L.-L. Gundersen, D. Petersen, B. T. Utenova, A. Vik, Org. Biol. Chem. 2005, 3, 1025-1033.
13. Ã. Proszenyák, M. BrAndvang, C. Charnock, L.-L. Gundersen, Tetrahedron 2009, 65, 194-199.
14. A. Vik, E. Hedner, C. Charnock, L. W. Tangen, Ã. Samuelsen, R. Larsson, L. Bohlin, L.-L. Gundersen, Bioorg. Med. Chem. 2007, 15, 4016-4037.
15. Ã. Proszenyák, C. Charnock, E. Hedner, R. Larsson, L. Bohlin, L.-L. Gundersen, Arch. Pharm. Chem. Life Sci. 2007, 340, 625-634.
16. M. Sjögren, M. Dahlström, E. Hedner, P. R. Jonsson, A. Vik, L.-L. Gundersen, L. Bohlin, Biofouling 2008, 24, 251-258.
17. A. Vik, Ã. Proszenyák, M. Vermeersch, P. Cos, L. Maes, L.-L. Gundersen, Molecules 2009, 14, 279-288.
18. H. Roggen, L.-L. Gundersen, Eur. J. Org. Chem. 2008, 5099-5106.
19. A. BrAthe, L.-L. Gundersen, K. E. Malterud, F. Rise, Arch. Pharm. Chem. Life Sci. 2005, 338, 159-166.
20. M. BrAndvang, L.-L. Gundersen, Bioorg. Med. Chem. 2007, 15, 7144-7165.
21. V. Bhowruth, L. G. Dover, G. S. Besra, Prog. Med. Chem. 2007, 45, 169-203.
22. M. BrAndvang, C. Charnock, L.-L. Gundersen, Bioorg. Med. Chem. Lett. 2009, 19, 3297-3299.
23. Committee. National, Clinical. for, Standards. Laboratory, Reference method for broth dilution antifungal susceptibility testing of yeasts, Approved standard M27-A, National Committee for Clinical Laboratory Standards, Wayne, PA 1997.
24. R. Larsson, A. P. Nygren, Anticancer Res. 1989, 9, 1111-1119.
25. E. Lindhagen, P. Nygren, R. Larsson, Nat Protoc. 2008, 3, 1364-1369.